Crestor to start first multinational trials "DISCOVERY" in Korea

Published: 2003-10-20 06:59:00

Updated: 2003-10-20 06:59:00

Pharmaceutical business sources say that local DISCOVERY trials for AstraZeneca's lead product Crestor for the treatment of hyperlipidemia are now underway with the initiative of a Korean chief investigator, with an aim to compare the efficacy and safety profiles of both rosuvastatin and atorvast...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK